Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harshad Devarbhavi

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Hepatology (Baltimore, Md.)|October 7, 2015
Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 casesHarshad Devarbhavi, Sujata Raj, Venu H Aradya, et al.
Journal of Medical Microbiology|June 2, 2012
Significant association of the dupA gene of Helicobacter pylori with duodenal ulcer development in a South-east Indian populationJawed Alam, Sankar Maiti, Prachetash Ghosh, et al.
Hepatology International|February 28, 2021
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelinesHarshad Devarbhavi, Guruprasad Aithal, Sombat Treeprasertsuk, et al.
Nature Reviews. Disease Primers|August 24, 2019
Drug-induced liver injuryRaul J Andrade, Naga Chalasani, Einar S Björnsson, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Journal of Clinical and Experimental Hepatology|February 16, 2019
Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of IndiaAabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
Corrigendum to "Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)" [J Clin Exp Hepatol 9 (2019) 74-98]Aabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Clinical and Experimental Hepatology|May 11, 2018
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsAnil Arora, Shivaram P Singh, Ashish Kumar, et al.
Scientific Reports|March 9, 2024
Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patientsKessarin Thanapirom, Sombat Treeprasertsuk, Ashok Choudhury, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2022
APASL-ACLF Research Consortium-Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patientsNipun Verma, Ashok Choudhury, Virendra Singh, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Hepatology (Baltimore, Md.)|October 7, 2015
Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 casesHarshad Devarbhavi, Sujata Raj, Venu H Aradya, et al.
Journal of Medical Microbiology|June 2, 2012
Significant association of the dupA gene of Helicobacter pylori with duodenal ulcer development in a South-east Indian populationJawed Alam, Sankar Maiti, Prachetash Ghosh, et al.
Hepatology International|February 28, 2021
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelinesHarshad Devarbhavi, Guruprasad Aithal, Sombat Treeprasertsuk, et al.
Nature Reviews. Disease Primers|August 24, 2019
Drug-induced liver injuryRaul J Andrade, Naga Chalasani, Einar S Björnsson, et al.
Clinical Pharmacology and Therapeutics|November 2, 2020
Genetic Risk Factors in Drug-Induced Liver Injury Due to Isoniazid-Containing Antituberculosis Drug RegimensPaola Nicoletti, Harshad Devarbhavi, Ashish Goel, et al.
Journal of Clinical and Experimental Hepatology|February 16, 2019
Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of IndiaAabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Clinical and Experimental Hepatology|February 7, 2020
Corrigendum to "Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)" [J Clin Exp Hepatol 9 (2019) 74-98]Aabha Nagral, Moinak S Sarma, John Matthai, et al.
Journal of Clinical and Experimental Hepatology|May 11, 2018
INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman StatementsAnil Arora, Shivaram P Singh, Ashish Kumar, et al.
Scientific Reports|March 9, 2024
Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patientsKessarin Thanapirom, Sombat Treeprasertsuk, Ashok Choudhury, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2022
APASL-ACLF Research Consortium-Artificial Intelligence (AARC-AI) model precisely predicts outcomes in acute-on-chronic liver failure patientsNipun Verma, Ashok Choudhury, Virendra Singh, et al.
Pageof 10